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Abstract
Influenza A virus (IAV) enters host cells upon binding of its hemagglutinin glycoprotein to sialylated host cell receptors.
Whereas dynamin-dependent, clathrin-mediated endocytosis (CME) is generally considered as the IAV infection pathway,
some observations suggest the occurrence of an as yet uncharacterized alternative entry route. By manipulating entry
parameters we established experimental conditions that allow the separate analysis of dynamin-dependent and
-independent entry of IAV. Whereas entry of IAV in phosphate-buffered saline could be completely inhibited by dynasore,
a specific inhibitor of dynamin, a dynasore-insensitive entry pathway became functional in the presence of fetal calf serum.
This finding was confirmed with the use of small interfering RNAs targeting dynamin-2. In the presence of serum, both IAV
entry pathways were operational. Under these conditions entry could be fully blocked by combined treatment with
dynasore and the amiloride derivative EIPA, the hallmark inhibitor of macropinocytosis, whereas either drug alone had no
effect. The sensitivity of the dynamin-independent entry pathway to inhibitors or dominant-negative mutants affecting
actomyosin dynamics as well as to a number of specific inhibitors of growth factor receptor tyrosine kinases and
downstream effectors thereof all point to the involvement of macropinocytosis in IAV entry. Consistently, IAV particles and
soluble FITC-dextran were shown to co-localize in cells in the same vesicles. Thus, in addition to the classical dynamin-
dependent, clathrin-mediated endocytosis pathway, IAV enters host cells by a dynamin-independent route that has all the
characteristics of macropinocytosis.
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Introduction
Influenza A virus (IAV) is an enveloped, segmented negative-
strand RNA virus infecting a wide variety of birds and mammals.
As its first step in infection IAV attaches to host cells by the
binding of its major surface protein, the hemagglutinin (HA), to
sialic acids, which are omnipresent on the glycolipids and
glycoproteins exposed on the surfaces of cells. Where the structural
requirements for this interaction have been studied in great detail,
much less is known about whether and how the attachment to
specific sialylated receptors (e.g. to N-linked glycoproteins, O-
linked glycoproteins or gangliosides or even to specific receptors
within these groups) affects the subsequent endocytic steps.
Obviously, knowledge about the repertoire of endocytic pathways
that can successfully be used by IAV will increase our insights into
cell and species tropism of IAV. In turn, this will contribute to our
understanding of the requirements for the generation of novel
viruses with pandemic potential that can arise by exchange of
RNA segments between currently circulating human serotypes
and an animal virus during occasional co-infection in a human or
an animal host.
Clathrin mediated endocytosis (CME) has for long been
identified and studied as the major route of IAV cell entry
[1,2] and is, by far, the best characterized endocytic pathway.
Evidence obtained from live cell imaging has revealed the de novo
formation of clathrin-coated pits at the site of virus attachment
[3] and the requirement for the adapter protein epsin 1, but not
eps15, in this process [4]. Still, specific transmembrane receptors
linking viral entry to epsin 1 or to other adapters have not been
identified although a recent study performed in CHO cells
indicated the specific requirement for N-linked glycoproteins in
IAV entry [5].
Some recent papers provided indications for the utilization of
alternative entry pathways by IAV. Studies in which CME was
obstructed by pharmacological or genetic intervention indicated
the ability of IAV to enter host cells via alternative endocytic
routes [4,6,7]. Also live cell imaging revealed the simultaneous
availability of entry routes involving non-coated as well as clathrin-
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been characterized in any detail and requirements for any
specificity in receptor usage apart from the need for the proper
sialic acid moiety have not been established.
During the past decades quite a variety of endocytic pathways
have been identified in eukaryotic cells [8,9,10]. Their occurrence,
abundance and mechanistic details appear to vary between cell
types, tissues and species and their utilization by viruses as a route
of entry makes them an important factor in host and cell-type
permissiveness for infection [11,12]. Besides by CME, different
viruses have been shown to enter cells via caveolae, macro-
pinocytosis or other, less well described, routes [11,12]. Most
often, the selection of a specific endocytic route is linked to the
utilization of a specific receptor that facilitates traveling via that
particular route. Nevertheless, many receptors allow flexibility by
their capacity to enter through multiple pathways. For IAV, an
additional level of complexity to the dissection of potential entry
routes is added by the apparent lack of an IAV-specific protein
receptor.
A full experimental characterization of the IAV entry pathways
will benefit from separation of the IAV entry pathways into routes
that can be studied independently. Whereas co-localization with
clathrin is an established marker for endocytosis via this route, the
complete lack of unique markers for macropinosomes or most
other endocytic compartments [13,14] complicates such studies.
Furthermore, crucial to any study concerning endocytic pathways
is the abundantly documented fact that such pathways are highly
dependent on experimental cell culture conditions [15–19].
Pathways that are constitutive in one cell type may be absent
or inducible by specific experimental conditions in other cell
types. Moreover, the manipulation of specific endocytic pathways
may result in up or down regulation of other specific pathways.
Here we have established entry assay conditions that allow
dissecting cell entry of IAV into a dynamin-dependent (DYNA-
DEP) and a dynamin-independent (DYNA-IND) component.
Dynamin is a large GTPase forming multimeric assemblies
around the neck of newly formed endocytic vesicles. GTP
hydrolysis is required for pinching off of the vesicles [20].
Whereas CME is completely dependent on dynamin, several
other endocytic routes do not require dynamin [21]. We
performed an extensive characterization of the dynamin-inde-
pendent IAV entry route using pharmacological inhibitors as well
as by expressing dominant-negative mutants and applying siRNA
induced gene silencing as tools. Taken together the results
identify a pathway that closely resembles macropinocytosis as a
novel entry pathway for IAV.
Results
A luciferase reporter assay for quantitative analysis of IAV
entry
To identify and characterize potential non-CME entry routes
taken by IAV, we adapted a luciferase reporter assay [22] to
enable the quantitative determination of infection or entry by
measuring the activity of secreted Gaussia luciferase. Twentyfour
hours prior to infection HeLa cells were transfected with a plasmid
(pHH-Gluc) allowing constitutive synthesis (driven by the human
PolI promoter) of a negative strand viral RNA (vRNA) encoding a
Gaussia luciferase under control of the untranslated regions
(UTRs) of the NP segment of Influenza A/WSN/33 (H1N1)
(hereafter called IAV-WSN) NP segment. Upon IAV infection, the
combined expression of the viral polymerase subunits and NP will
drive transcription of luciferase mRNA from the negative strand
vRNA and subsequent synthesis of Gaussia luciferase.
A dose-response curve demonstrating the applicability of the
assay to inhibitor screening (Fig. 1A) was obtained for Bafilomycin
A1 (BafA1), a known inhibitor of IAV entry [23]. BafA1 acts upon
the vacuolar-type H(+)-ATPase, thus preventing endosomal acid-
ification and thereby trapping IAV in peri-nuclear immature
endosomes with a lumenal pH that does not permit viral membrane
fusion. Remarkably, dynasore, a small molecule inhibitor of the
GTPase dynamin 2 that is crucial for endocytic vesicle formation in
clathrin- and caveolin-mediated endocytosis [8] as well as in a
poorly described clathrin- and caveolin-independent endocytic
pathway [8,19], did not give significant inhibition (Fig. 1B).
BafA1 specifically inhibits IAV during the entry phase as
demonstrated in Fig. 1C. The continuous presence of 10 nM
BafA1 (added to the cells 1 hr prior to infection) for 16 hrs
completely prevents infection. In contrast the addition of BafA1 at
1 hr or 2 hrs post infection resulted in high levels of luciferase
activity (again measured at 16 hrs p.i.) that were 63% or 90%
respectively of the control to which no BafA1 was added,
indicating that entry was essentially completed within 2 hrs. The
last bar of Fig. 1C shows that the inhibition by BafA1 is reversible
as withdrawal of the inhibitor after 2 hrs resulted in high levels of
infection. The specific effect of BafA1 on IAV entry was confirmed
by confocal microscopy demonstrating that BafA1, as expected,
traps IAV particles in a peri-nuclear location, presumably in non-
acidified endosomes (Fig. 1D). BafA1 was subsequently exploited
to establish a specific IAV entry assay (hereafter further referred to
as the Gluc-entry assay). HeLa cells transfected with pHH-Gluc
were inoculated with IAV at a range of MOIs and incubated for
2 hrs after which the entry medium was replaced by complete
growth medium containing 10% FCS and 10 nM BafA1 to
prevent any further entry of virus. Entry was indirectly quantified
by determination of luciferase activity after further incubation for
14 hrs demonstrating a quantitative correlation between infection
dose and luciferase activity across a wide range of MOIs (Fig. 1E).
The indirect Gluc-entry assay was next tested for its capacity to
examine the effects of inhibitors on IAV entry. Dynasore or BafA1
(Fig. 1F) were included in the medium (DMEM containing 10%
Author Summary
Attachment to and entry into a host cell are the first crucial
steps in establishing a successful virus infection and critical
factors in determining host cell and species tropism.
Influenza A virus (IAV) attaches to host cells by binding of
its major surface protein, hemagglutinin, to sialic acids that
are omnipresent on the glycolipids and glycoproteins
exposed on the surfaces of cells. IAV subsequently enters
cells of birds and a wide variety of mammals via receptor-
mediated endocytosis using clathrin as well as via (an)
alternative uncharacterized route(s). The elucidation of the
endocytic pathways taken by IAV has been hampered by
their apparent redundancy in establishing a productive
infection. By manipulating the entry conditions we have
established experimental settings that allow the separate
analysis of dynamin-dependent (including clathrin-medi-
ated endocytosis) and independent entry of IAV. Collec-
tively, our results indicate macropinocytosis, the main
route for the non-selective uptake of extracellular fluid by
cells, as an alternative IAV entry route. As the dynamin-
dependent and -independent IAV entry routes are
redundant and independent, their separate manipulation
was crucial for the identification and characterization of
the alternative IAV entry route. A similar strategy might be
applicable to the study of endocytic pathways taken by
other viruses.
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when the inoculum was replaced by growth medium containing
BafA1. Concentrations up to 80 mM dynasore did not inhibit entry
which is in agreement with the result shown in Fig. 1B. In contrast,
1.25 nM BafA1 already inhibited entry for more than 60%
(Fig. 1F). As a control, dynasore was also added at 2 hrs post
infection to analyze whether the drug affected IAV replication
during the post entry phase. As expected, 80 mM dynasore did not
significantly inhibit IAV replication when present from 2 to 16 hrs
p.i. (Fig. 1F). Thus, with the Gluc-entry assay we can study the
effect of specific inhibitors on IAV entry in a quantitative manner,
at least as long as the inhibitors do not irreversibly affect IAV
replication during the post entry phase.
Furthermore, the lack of inhibition of IAV entry by dynasore
demonstrates that under these experimental conditions IAV is able
to enter cells via a pathway that is fully redundant to any dynamin-
dependent (DYNA-DEP) entry route, including the classical CME
pathway. Also when IAV travels via this novel dynamin-
independent (DYNA-IND) route, IAV apparently enters via low
pH compartments as entry is fully sensitive to BafA1.
Induction of a DYNA-IND IAV entry pathway by serum
As factors present in serum are known for their potential to
induce specific endocytic pathways, we further explored the
conditions required for the novel DYNA-IND IAV entry pathway
(using the Gluc-entry assay) by inoculating cells in PBS in the
presence of increasing concentrations of fetal calf serum (FCS).
Whereas dynasore completely inhibited entry in PBS, inclusion of
5% and 10% FCS resulted in increasing levels of dynasore resistant
entry (Fig. 2A), suggesting the existence of a serum-inducible
DYNA-IND IAV entry pathway. This effect was not caused by
inactivation of dynasore during the experiment as vesicular
stomatitis virus (VSV), which enters cells by CME [24,25], was
still sensitive to 80 mM dynasore in the presence of 10% FCS
(Fig. 2B). In agreement herewith, the uptake of transferin, known to
occur via CME, was inhibited by dynasore regardless of the
Figure 1. A luciferase reporter assay for quantitative analysis of IAV entry. (A, and B) HeLa cells were transfected with the IAV reporter
plasmid pHH-Gluc 24 hrs before infection. Inhibitors were added at 1 hr before infection with IAV (strain WSN; MOI of 0.1). Cells were kept at 37uCi n
DMEM supplemented with 10% FCS at all times. Luciferase activity (RLU, Relative Light Units) was measured 16 hrs p.i. and plotted on the Y-axes
relative to the control (infection in presence of 0.2% DMSO, the solvent of both inhibitors) (error bars represent S.D. derived from triplicates). (A)
Inhibitory effect of BafA1 (concentration range 0.625 nM to 10 nM on the x-axis) (B) Inhibitory effect of Dynasore (concentration range 20 to 160 mM
on the x-axis) (C) The effect of the presence of 10 nM BafA1 during different periods (21 hr to 16 hrs p.i.; 1 hr to 16 hrs p.i.; 2 hrs to 16 hrs p.i. and
21 hr to 2 hrs p.i as plotted on the x-axis) of a multi-cycle infection with IAV (strain WSN; MOI 0.5). Y-axis and control as in panel A and B. BafA1 was
only strongly inhibitory when already present before inoculation with IAV. Reversibility of inhibition was shown upon withdrawal of BafA1 at 2 hrs p.i.
(21 hr to 2 hrs). (D) Examination of the effect of 10 nM BafA1 on subcellular localization of IAV particles by confocal fluorescence microscopy. HeLa
cells were grown on glass cover slips and infected with IAV (strain WSN; MOI of 10) and fixated after 30 min, 3 hrs or 6 hrs (column 1, 2 or 3
respectively). Infection was performed in 0.2% DMSO (upper row panels) or in the presence of 10 nM BafA1 (lower row panels). The nucleus was
visualized by DNA staining with TOPRO-3 (red). IAV infection was visualized by staining with monoclonal antiserum directed against NP (green). In the
absence of inhibitor, IAV localized to the nucleus after 3 hrs, while new virus particles spread to the cytoplasm after 6 hrs. BafA1 (lower row panels)
caused accumulation of incoming virus particles at a peri-nuclear location. (E) Quantitative determination of IAV entry by a single-cycle Gluc-entry
assay. HeLa cells (10,000 cells/well in DMEM supplemented with 10% FCS) were transfected with pHH-Gluc 24 hrs prior to infection with a serial
dilution of infectious IAV particles (plotted on the x-axis). Two hours after infection 10 nM BafA1 was added to block any further entry. Cells were
incubated for a further 14 hrs to allow expression of luciferase activity (y-axis; Relative Light Units, RLU). (F) Effect of Dynasore and BafA1 on IAV entry
in the Gluc-entry assay. Dynasore (DY, dark grey bars; 20, 40 or 80 mM) or BafA1 (light grey bars; 1.25, 2.5 or 5 nM) were present from 1 hr prior to
infection (strain WSN; MOI 0.5) to 2 hrs p.i. after which the inhibitor-containing medium was replaced with medium containing 10 nM BafA1 to block
any further entry. Cells were incubated for a further 14 hrs to allow the quantitative expression of luciferase activity (y-axes; RLU relative to the
control infection without inhibitor). Whereas BafA1 displayed dose-dependent inhibition of IAV entry, dynasore did not significantly inhibit IAV entry.
Addition of Dynasore (DY, 20, 40 or 80 mM) at 2 hrs p.i. (black bars; MOI 0.5; no inhibitors present from 21 to 2 hrs) demonstrated that Dynasore does
not have a post-entry effect.
doi:10.1371/journal.ppat.1001329.g001
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PLoS Pathogens | www.plospathogens.org 3 March 2011 | Volume 7 | Issue 3 | e1001329Figure 2. Serum induces a Dynasore resistant entry route. (A) The effect of increasing concentrations of FCS (in PBS) on IAV entry. HeLa cells
were infected in the absence (grey bars) or presence (black bars) of 80 mM dynasore with IAV (strain WSN; MOI 0.5) using the Gluc-entry assay. Entry
was determined in presence of increasing concentrations of FCS (plotted on the x-axis). Luciferase activity was determined 16 hrs p.i. (plotted on the
y-axis relative to the activity obtained in absence of dynasore (grey bars, 100%) for each concentration of FCS. Entry of IAV became completely
dynasore-resistant in the presence of 10% FCS. (B) Inhibition of VSV entry by 80 mM dynasore (DY) in presence of 10% FCS. HeLa cells were infected
with VSV in PBS or PBS+10% FCS (labeled 10% FCS) in absence (grey bars) or presence (black bars) of 80 mM dynasore (DY). In presence of 10% FCS
VSV infection appears still to be fully sensitive to dynasore. (C) IAV entry via the dynamin-dependent (DYNA-DEP) or dynamin-independent (DYNA-
IND) route depends on the presence of sialic acid receptors. Hela cells were treated with V. cholerae neuraminidase (NEU; black bars) or mock-treated
(-; grey bars) prior to infection in order to remove surface exposed sialic acids. Cells were infected (strain WSN; MOI 0,5) using the Gluc-entry assay.
DYNA-DEP entry was determined in PBS and DYNA-IND entry in PBS containing 10% FCS and 80 mM dynasore. Both pathways appear to be equally
sensitive to de-sialylation of cells. (D) Comparison of the kinetics of DYNA-DEP IAV entry and DYNA-IND IAV entry. DYNA-DEP entry was determined in
PBS and DYNA-IND entry in PBS containing 10% FCS and 80 mM dynasore (80 DY) using the Gluc-entry assay as described for panel C. Entry was
allowed to proceed for 15 to 240 minutes (x-axis) by the addition of full growth medium containing 10 nM BafA1 at the indicated timepoints p.i.
Luciferase activity was plotted in absolute RLU (y-axis), demonstrating that similar entry efficiencies were obtained via the two pathways after 4 hrs of
entry. The experiment was repeated several times with different batches of serum yielding similar results.
doi:10.1371/journal.ppat.1001329.g002
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entry in PBS and DYNA-IND entry in the presence of 10% FCS
and 80 mM dynasore required sialicacid receptors for efficient entry
as pre-treatment of HeLa cells with neuraminidases almost
completely abolished entry via either pathway (Fig. 2C). The
kinetics of the DYNA-DEP and DYNA-IND entry pathways were
compared by performing a time-course experiment in which IAV
entry was terminated by the addition of 10 nM BafA1 at different
time points (Fig. 2D). In comparison to entry via the DYNA-DEP
pathway(theonlypathwayavailableinPBS)entryinthepresenceof
FCS (when presumably both the DYNA-DEP and DYNA-IND
entry pathways are available) showed similar kinetics. In contrast,
entry via the DYNA-IND pathway (which is the only pathway that
is active in the presence of 10% FCS and 80 mM dynasore) was
slower. The differencewas most prominent after 15 min, while after
4 hrs similar levels of entry were reached.
To validate and extend these results we visualized the reduction
of the number of infected cells by immunoperoxidase staining
using an antibody against NP (Fig. 3). A number of different cells
of mammalian and avian origin were infected for 2 hours at an
MOI of 1 in PBS with or without serum. After 2 hours the
inoculum was replaced by growth medium containing 10% FCS
and 10 nM BafA1 and the expression of NP was examined after
14 hours later. After incubation in PBS, staining was completely
prohibited by the presence of 80 mM dynasore whereas in the
presence of serum dynasore had no effect. A serum-inducible,
DYNA-IND route of entry was thus functional in all five cell lines,
including the human epithelial airway carcinoma cell line A549.
To confirm our results and to obtain further proof for the
utilization of DYNA-DEP and DYNA-IND entry routes by IAV,
we additionally used an IAV virus-like particle (VLP) direct entry
assay [26]. These VLPs contain IAV HA and NA in their
envelope and harbor a beta-lactamase reporter protein fused to
the influenza matrix protein-1 (BlaM1), which allows the rapid
and direct detection of entry, independent of virus replication.
Upon fusion of viral and endosomal membrane, BlaM1 gains
access to the cytoplasmically retained fluorigenic substrate CCF-
2 that, after cleavage by BlaM1, shifts to a shorter fluorescent
emission wavelength that can be detected by flow cytometry.
Entry into HeLa cells was performed in the absence or presence
of 10% FCS using VLPs containing HA and NA either from
IAV-WSN (having a strict alpha 2–3 linked sialic acid binding
specificity) or from the pandemic 1918 IAV (HA from A/
NewYork/1/18, binding to alpha 2–3 and alpha 2–6 linked sialic
acids; NA from A/BrevigMission/1/18). Entry of VLPs of both
IAV strains was severely inhibited by dynasore when no serum
was added to the inoculum (Fig. 4A, 4D), whereas the presence
of 10% FCS rendered entry completely dynasore resistant.
(Fig. 4B, 4E). Quantification of VLP entry is shown in Fig. 4C
and F.
Importantly, to confirm the existence of the serum-inducible
entry pathway by a method that is independent of dynasore, we
used siRNA induced silencing of dynamin 2. Fig. 4G shows that
two different siRNAs had a significant inhibitory effect (48 hrs
after siRNA transfection) on entry of the Renilla luciferase-
encoding pseudovirus WSN-Ren [27] in HeLa cells in the
absence of FCS, whereas the presence of 10% serum no
reduction in entry levels was observed, confirming the results
obtained with dynasore. Knockdown of dynamin 2 protein levels
(48 hrs after siRNA transfection) was analyzed by western
Figure 3. Serum-inducible DYNA-IND IAV entry in different cell types. HeLa cells, A549 cells (human epithelial lung carcinoma cells), MDCK
cells (canine kidney cells), DF-1 cells (chicken embryonic fibroblast cells) and E-36 cells (Chinese hamster lung cells) were infected with IAV (MOI 2) in
PBS or in PBS supplemented with 10% FCS in the absence or presence of 80 mM dynasore (DY). After 2 hrs the entry medium was replaced by growth
medium (DMEM with 10% FCS and 10 nM BafA1) and infection was continued for 14 h after which the cells were fixed, permeabilized and stained
with a monoclonal antibody against NP (detection by peroxidase staining).
doi:10.1371/journal.ppat.1001329.g003
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knockdown of dynamin 2 mRNA levels as determined by
quantitative RT-PCR.
We conclude that a DYNA-IND entry pathway can be induced
by serum in different cell types from several species. The evidence
was obtained using both replication-dependent (Gluc-entry assay
and immunodetection of infected cells) and replication-indepen-
dent assays (entry of VLPs), the latter allowing immediate
detection of the fusion-mediated delivery of viral M1 protein into
the cytoplasm.
Figure 4. Identification of DYNA-IND entry in a VLP entry assay and by siRNA knockdown of dynamin 2. FACS histograms displaying
the entry of IAV VLPs, containing the BlaM1 reporter and carrying either the WSN (A and B) or the 1918 (D and E) HA and NA, in Optimem (OPTI)
without (A and D) or with (B and E) 10% FCS, and in the absence (red lines) or presence (blue lines) of 80 mM dynasore are shown. Release of BlaM1
into the cytoplasm upon VLP fusion results in cleavage of the CCF2 substrate thereby causing emission of a fluorescent signal at 447 nm (X-axis;
Cascade Blue). In the histograms entry is displayed by a shift to higher fluorescence (the grey area represents background fluorescence of non-
infected cells). (C and F) Quantification of FACS results. Background fluorescence was subtracted from each measurement (geometric mean) and data
were normalized to VLP entry in Optimem without dynasore (DY) (red curve of panel A and and D). VLP entry was not inhibited by dynasore in
presence of 10% FCS whereas the access of BlaM1 to its CCF2 substrate in the cytoplasm was blocked by dynasore in PBS. VLP entry was more
efficient in the presence of serum. (G) Effect of downregulation of dynamin 2 by siRNA silencing. Serum-inducible DYNA-IND entry was analyzed in
HeLa cells that were transfected 48 hrs prior to infection with two different siRNAs targeting dynamin-2 (dyna). siRNA treated cells were infected with
the pseudovirus WSN-Ren in PBS (grey bars) or in PBS containing 10% FCS (black bars) and luciferase activity was determined after 16 hrs post
infection (y-axis; RLU relative to infection of cells transfected with a scrambled siRNA). Entry of pseudovirus WSN-Ren (MOI 0.5) was reduced by 50%
to 70% when entry was performed in PBS (grey bars) whereas entry was not significantly affected in the presence of 10% serum (black bars). (H)
Western blot showing the knockdown of dynamin 2 (in comparison to tubulin) at 48 hrs after transfection with siRNAs. (I) Quantification of the
residual levels of dynamin 2 (dyna) mRNA (determined by quantitative RT-PCR) and protein (determined by densitometric scanning of the western
blot) 48 hrs after siRNA transfection. Data were normalized to 18S RNA (RT-PCR) or tubulin protein levels and calculated relative to the levels obtained
after transfection with a scrambled siRNA that served as a control.
doi:10.1371/journal.ppat.1001329.g004
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actomyosin network dynamics reduce DYNA-IND entry of
IAV
The DYNA-IND entry pathway was further characterized by
inhibitor profiling using an 80-compound kinase inhibitor library.
Serum-induced DYNA-IND entry was examined in 10% FCS
using the Gluc-entry assay. 80 mM dynasore was added in order to
block CME and any other potential DYNA-DEP entry pathways.
This allowed the independent inhibitor profiling of the novel
pathway by avoiding the potentially masking effect of the presence
of redundant entry pathways. Cells were preincubated with the
kinase inhibitors (10 mM) for 1 h at 37uC and then inoculated with
virus (MOI 0.5) in the presence of 10% FCS and 80 mM dynasore
for 2 h at 37uC (DYNA-IND entry). In parallel, inoculations were
also done in PBS to compare the effects of the inhibitors on
DYNA-DEP entry. After 2 hr the medium and inhibitor were
replaced by full growth medium containing 10% FCS and 10 nM
BafA1 to allow the subsequent expression of Gluc activity under
identical conditions for the DYNA-IND and -dependent entry
assay. Six kinase inhibitors appeared to act non-discriminatively,
inhibiting both DYNA-DEP and DYNA-IND entry (Fig. 5A): the
protein kinase C (PKC) inhibitors Ro 31-8220, rottlerin (both
displaying moderate cytotoxicity, result not shown) and hypericin,
which have all three been previously identified as IAV inhibitors
[28,29]; the highly cytotoxic pan-specific serine/threonine prote-
ase inhibitor staurosporine; the irreversible PI-3 kinase inhibitor
wortmannin and the receptor tyrosine kinase inhibitor TYR9. In
order to investigate whether some of these inhibitors affect IAV
replication during the post-entry phase, we performed the same
experiments but now adding the kinase inhibitors after viral entry.
Four of the inhibitors thus appeared to induce significant
inhibition of post-entry processes (Fig. 5A). Although unlikely,
we cannot formally exclude that post-entry processes specific for
only one of the two entry pathways are affected. Interestingly,
whereas no specific DYNA-DEP entry inhibitors were identified,
15 inhibitors (none displaying cytotoxic effects, data not shown)
caused significant (p,0.05) inhibition (.5-fold) of DYNA-IND
entry (Fig. 5B). This included inhibitors of the calmodulin
dependent kinases myosin light chain kinase (MLCK) and
CaMKII and seven inhibitors of different growth factor receptor
tyrosine kinases. In contrast to the three non-specific PKC
inhibitors mentioned above, the PKC inhibitors BIM-1 and
HBDDE appeared to have a specific inhibitory effect on DYNA-
IND entry. The specific effect of these drugs on DYNA-IND entry
is not only shown by the lack of inhibition of DYNA-DEP entry in
PBS, but also by the observation that none of the fifteen
compounds induced .2-fold inhibition when added post-entry
(at t=2 hr post infection). The kinase library screen was repeated
on A549 human epithelial lung carcinoma cells in order to confirm
the results in a potentially more natural host cell line. The
inhibition profiles obtained were very similar to those found for
HeLa cells with the exception of the strong effect of AG879 (99%
inhibition) and moderate effects of AG825 (39% inhibition) and
Tyr51 (68% inhibition) on DYNA-DEP entry. (Fig. 5C).
MLCK inhibitors ML-7 and ML-9 have been reported to be
highly specific for their target kinase [30]. Phosphorylation by
MLCK activates non-muscle myosin II light chain, indicating that
a functional actomyosin network might be essential for DYNA-
IND entry of IAV. This was further examined by testing the effect
of Blebbistatin, an inhibitor of myosin II heavy chain activity, and
of several inhibitors that affect actin dynamics by disrupting actin
microfilaments (Cytochalasin B and D), by enhancing actin
polymerization (Jasplakinolide) or by inhibiting actin polymeriza-
tion (Latrunculin A). Actin inhibitors were used at the minimal
concentration required to induce clearly visible changes in the
actin cytoskeleton as pre-determined by staining with FITC-
phalloidin (results not shown). Whereas the inhibitors did not
affect DYNA-DEP entry (Fig. 6A) using Gluc-entry assay, all
inhibitors as well as ML-7 and ML-9 significantly inhibited
DYNA-IND entry (Fig. 6B).
Next, HeLa cells were transfected with plasmids encoding
dominant negative or wildtype Rab5 fused to green fluorescent
protein (Rab5 DN and Rab5 wt in Fig. 6) 24 h prior to infection
with IAV. Rab5 is a small GTPase found in association with
several endosomal compartments and crucial for the function and
maturation of early endosomes. It is required for the trafficking of
a wide range of endocytic cargo following different routes,
including DYNA-DEP as well as DYNA-IND routes [31]. Entry
of IAV has been shown to require Rab5 [32]. Consistently, we
found that HeLa cells expressing Rab5 DN (as identified by GFP
fluorescence, Fig. 6C) were much less susceptible to productive
IAV infection (as judged by indirect immunofluorescence using
Alexa-488 labeled NP antibodies) than cells transfected with Rab5
wt, both by DYNA-DEP (64% inhibition) and by DYNA-IND
(47% inhibition) routes (Fig. 6D). In contrast, when examining the
efficiency of DYNA-DEP and DYNA-IND entry routes in cells
transfected with a dominant negative mutant of MLCK (MLCK
DN; examined in comparison to MLCK wt), only IAV infection
under DYNA-IND conditions was significantly reduced (Fig. 6E;
53% inhibition). Similarly, a construct encoding the N-terminal
head domain of myosin II MyoII-head) also only significantly
affected DYNA-IND entry (Fig. 6F; 92% inhibition). The
combined results indicate that a dynamic actomyosin network
requiring the activation of myosin II by MLCK is necessary for
efficient entry of IAV via a DYNA-IND pathway.
DYNA-IND IAV entry follows a pathway with similarities
to macropinocytosis
Several dynamin-independent endocytic pathways have been
described [8,19]. Of these, macropinocytosis has been demon-
strated to be stimulated by growth factors present in serum and to
depend on actin dynamics [12–14]. Yet, studies on macropino-
cytosis are hampered by a lack of specific inhibitors, cargo,
membrane markers and characteristic morphology. Amiloride and
the more potent derivative EIPA are inhibitors of epithelial sodium
channels (ENaC) as well as of several other Na+/H+ antiporters.
EIPA has often been used as a hallmark inhibitor that specifically
inhibits endocytosis via the macropinocytic pathway [14].
Whereas DYNA-DEP entry of IAV was not inhibited by EIPA
(Fig. 7A), DYNA-IND entry was fully blocked EIPA (Fig. 7B). The
existence of redundant entry pathways in the presence of 10%
FCS is clearly demonstrated by the marginal inhibition by either
EIPA or dynasore whereas the combination of EIPA and dynasore
resulted in strong inhibition both in the Gluc-entry assay (Fig. 7C)
and in the direct VLP entry assay (Fig. 7D and E). Supplementary
Fig. S1 shows that other cell lines, including the human lung
epithelial cell line A549, display similar IAV inhibition patterns for
EIPA and dynasore. Consistently, virus production displayed a
similar inhibitor sensitivity profile (Fig.7 F and G) as virus entry
indicating that the entry pathways we characterized lead to a
productive infection. Clearly, VLPs and viral particles follow
similar redundant entry pathways, distinguishable in a DYNA-
DEP and a DYNA-IND pathway, the latter being sensitive to
EIPA and dependent on actomyosin function.
One characteristic of macropinocytosis is the nonselective
uptake of large amounts of extracellular solutes [33]. Therefore,
the uptake of soluble FITC labeled dextran (Fdx) into relatively
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morphological marker for macropinosomes. Using this marker
we found that the addition of 10% FCS to the culture medium
slightly increased the uptake of Fdx into HeLa cells (Fig. 8A).
Notably, the distribution of Fdx changes in response to serum from
a random distribution into a more granular pattern. At high
Figure 5. Screening of an eighty-compound protein kinase inhibitor library in an IAV entry assay. HeLa cells were incubated with kinase
inhibitors at a concentration of 10 mM from 1 hr prior to infection (strain WSN; MOI 0.5). Entry (Gluc-entry assay) was performed for 2 hrs in the
presence of the inhibitors under DYNA-DEP entry conditions (entry in PBS; black bars) and DYNA-IND entry conditions (entry in PBS supplemented
with 10% FCS and 80 mM dynasore; grey bars. In addition, all inhibitors were added 2 hrs p.i. to cells that had not been treated with inhibitors during
entry (in presence of 10% FCS) in order to screen for post-entry effects (striped bars). (A) Inhibitors that were inhibitory for both entry routes and
mostly also affected post-entry events. (B) Inhibitors that affect DYNA-IND entry but neither displayed effects on DYNA-DEP entry or post-entry
effects. (C) All kinase inhibitors were also screened on A549 cells. Black and grey bars correspond to DYNA-DEP and DYNA-IND entry. (D) Targets of
inhibition of the different kinase inhibitors are listed. All inhibitors have been tested at a standard concentration of 10 mM. Whereas for some
inhibitors higher concentrations may be required for efficient inhibition of their specific target, for other inhibitors this concentration is relatively high
and other targets may be inhibited as well. For instance wortmannin is known to inhibit PI4 kinase and MLCK at a 10 mM concentration.
doi:10.1371/journal.ppat.1001329.g005
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could be seen that these Fdx granules were free of actin staining
(by phalloidin) indicating that they were in the lumen of vesicles
(result not shown). Interestingly, in the presence of IAV (MOI of
10) the uptake of Fdx into vesicles was clearly enhanced. At a
higher magnification viral particles could be found to co-localize in
Fdx loaded vesicles as well as outside these vesicles (Fig. 8B).
Phalloidin staining of actin was used to demonstrate that many
virus particles localized to actin-rich protrusions at the periphery
of the cell. The uptake of Fdx was studied in a quantitative manner
by flow cytometry (Fig. 8 C). A moderate, but reproducible shift to
higher Fdx fluorescence was observed at 37uC when virus was
added in presence of 10% FCS whereas such a shift was absent
when no serum or virus was added. This result confirms the
observations by confocal microscopy (Fig. 8A) which showed that
the combined presence of FCS and IAV increases the uptake of
Fdx as compared to FCS alone. In a control experiment the
uptake of Fdx in 10% FCS in presence of IAV was shown to be
specifically inhibited by EIPA, but not by dynasore (Fig. S2, panel
B). In contrast, transferrin uptake, which serves as a specific
marker for CME, was affected by dynasore, but not by EIPA (Fig.
S2, panel A).
In conclusion,serum induces the uptakeofFdxinto large vesicles,
whichcanbefurtherenhancedbytheadditionofIAVparticlesthat,
after entry, co-localize in part with these vesicles. These results
indicate the utilization of a macropinocytic pathway for entry of
IAV, which is consistent with the observed sensitivity of the serum-
inducible DYNA-IND entry of IAV and VLPs to EIPA.
IAV entry via macropinocytosis depends on PAK1 and src
Macropinocytosis has been implicated in the entry of several
viruses [12,14]. However, differences in susceptibility to inhibitors
suggest that distinct forms of macropinocytosis might be used by
different viruses [34,35]. By screening specific inhibitors in the
Gluc-entry assay using DYNA-IND entry conditions we evaluated
the possible involvement of a few signaling cascades that have been
Figure 6. Actomyosin network dynamics are required for DYNA-IND entry by IAV. (A and B) Compounds affecting actin polymerization/
de-polymerization (20 mM cytochalasin D [CYTD], 20 mM cytochalasin B [CYTB], 1 mM Latrunculin A [LATR], 1 mM Jasplakinolide [JASP]), inhibitors of
MLCK (5 mM ML-7 and 5 mM ML-9) and an inhibitor of myosin II, (80 mM Blebbistatin [BLEB]) were examined for their effect on DYNA-IND IAV entry in
PBS (A) or DYNA-DEP IAV entry (in PBS, 10% FCS and 80 mM dynasor) (B) using the Gluc-entry assay (HeLa cells; strain WSN; MOI 0.5; incubation with
inhibitors from 1 hr prior to infection to 2 hrs p.i.). Luciferase activity was determined 16 hrs p.i. (RLU plotted on the y-axis relative to the activity
obtained in absence of compounds affecting the actomysoin network (grey bars, 100%). (C) An example of confocal images of HeLa cells, expressing
a wildtype Rab5-GFP fusion protein (Rab5 wt) (upper panel, green fluorescence identifies transfected cells) or a dominant-negative mutant of a Rab5-
GFP fusion protein (RAB5 DN; lower panel), inoculated with IAV (strain WSN; MOI 1). Infection was performed for 4 hrs after which cells were fixed and
stained (red staining with a monoclonal antibody directed against NP identifies infected cells; In the example of panel C infection was performed in
PBS in order to examine the DYNA-DEP entry pathway) Similar experiments were performed for GFP fusion proteins with dominant-negative and
wildtype MLCK (MLCK DN and MLCK wt) and Myosin II-tail domain (MyoII-tail) or MyosinII-head domain (MyoII-head). Transfected cells were infected
under DYNA-DEP (PBS) and DYNA-IND (PBS, 10% FCS and 80 mM dynasor) entry conditions. (D–F) Results were quantified by counting .100 cells
(experiment performed in triplo; transfected cells, infected cells and cells that were transfected as well as infected were counted). Relative infection of
transfected cells was plotted (taking infection of non-transfected cells in the same sample as 100%). Thus, whereas Rab5 wt transfected cells are not
significantly reduced or enhanced in infection compared to non-transfected cells (D, black bars), Rab5 DN transfected cells (D, grey bars) are infected
at lower levels both under DYNA-DEP and DYNA-IND entry conditions. In contrast, cells transfected with MCLK DN (E) or MyoII-head (F) were infected
at significantly lower levels via the DYNA-IND pathway while the DYNA-DEP pathway was not affected. Transfection efficiency for the different
constructs was as follows: RAB5 wt (61%); RAB5 DN (45%); MLCK wt (50%); MLCK DN (49%); MyoII-tail (69%); MyoII-head (55%).
doi:10.1371/journal.ppat.1001329.g006
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in the Gluc-entry assay (HeLa cells; strain WSN; MOI 0.5; incubation with EIPA from 21 hr to 2 hr p.i.). Data were plotted relative to the control (0.2%
DMSO). (C) Redundancy of DYNA-DEP and DYNA-IND entry pathways in 10% FCS using the Gluc-entry assay. The effect of 80 mM dynasore (DY; red),
80 mM EIPA (orange) or 80 mM of both inhibitors (DY+EI; green) in the presence of 10% FCS is shown (HeLa cells; strain WSN; MOI 0.5). (D,E)
Redundancy of DYNA-DEP and DYNA-IND entry pathways in 10% FCS using the VLP entry assay. VLP entry was performed in Optimem containing
10% serum in the presence of 80 mM dynasore (DY; red), 80 mM EIPA (orange) or 80 mM of both inhibitors (DY+EI; green). Panel E displays the
quantified data of the FACS histograms displayed in panel D. (F,G) Virus production was measured by determining infectivity in the supernatant of
cells inoculated in the presence of 80 mM dynasore (DY), 80 mM EIPA or 80 mM of both inhibitors (DY+EI) in PBS (panel E) or PBS+10% FCS (panel F).
After 2 hr the medium was replaced by growth medium containing 10% FCS and 10 nM BafA1. Supernatant was harvested 24 hr p.i. for TCID50
determination (Y-axis).
doi:10.1371/journal.ppat.1001329.g007
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macropinocytosis has been shown to be activated via a myriad of
signaling cascades initiated by growth factors binding to
transmembrane tyrosine kinase receptors [14,17,36,37], consistent
with the results shown in Fig. 5. A prominent downstream effect of
these signaling cascades is the activation of p21 associated kinase 1
(PAK1) which in turn can activate a number of different pathways
leading to actin network rearrangements that can ultimately lead
to the induction of macropinocytosis [38]. Fig. 9A–B shows that
20 mM IPA3, an inhibitor of PAK1 [39], specifically inhibits
Figure 8. Induction of uptake of dextran into vesicles by the combined action of serum and IAV. (A) Uptake of FITC-dextran (Fdx; green)
into HeLa cells in PBS, PBS+10% serum or PBS+10% serum+IAV (MOI=10) was studied by confocal microscopy. IAV was detected by fluorescence
staining with monoclonal antibody directed against NP. The actin network of cells was stained by phalloidin. Whereas vesicular structures containing
Fdx become visible in the presence of serum, these structures become much more apparent in the simultaneous presence of serum and IAV. (B) A
magnification of Panel A demonstrating the co-localization of Fdx and IAV in vesicular structures (arrows). (C) Quantification of dextran uptake in
presence or absence of IAV by FACS analysis. Fdx uptake was performed for 15 min at 37uC in PBS (grey bars) or in PBS containing 10% FCS (black
bars) in absence or presence of IAV (strain WSN; MOI 10) as indicated at the x-axis. Background fluorescence from Fdx binding to the outside of cells
was determined by performing the same experiment at 4uC (at which no endocytosis takes place) and was subtracted from the mean fluorescence
intensity obtained at 37uC to determine the amount of fluorescent FITC-dextran that was internalized at 37uC. Data were plotted relative to FITC-
dextran uptake in PBS in absence of IAV.
doi:10.1371/journal.ppat.1001329.g008
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growth factor stimulation often involves upstream signal trans-
duction by members of the Rho sub-family of small GTPases like
CDC42 and/or Rac1 [34,40,41]. Alternatively, activated CDC42
and Rac1 can induce actin rearrangements independently of
PAK1 [34,40–43] by direct interaction with WASP or WAVE
family proteins, respectively [44,45]. However, inhibitors of
CDC42 (Pirl1 [46]), Rac1 (NSC23766 [47]) or N-WASP
(wiskostatin [48]) did not display inhibitory effects on DYNA-
IND or DYNA-DEP entry of IAV (Fig. 9C–D). Instead, Pirl1 and
wiskostatin induced a significant, concentration dependent in-
crease of entry. This stimulatory effect was not observed for the
control vaccinia virus strain WR, which enters cells via a Rac1-
dependent, macropinocytotic pathway [43] (Fig. 9E), indicating
that this effect is specific for IAV. The results suggest a
requirement for PAK1 in DYNA-IND entry of IAV that does
not require activation by either CDC42 or Rac1. Growth factor
inducible activation of the tyrosine kinase src has also been linked
to the induction of macropinocytosis [49–51]; consistent with this
observation the src inhibitor PP2 [52] specifically inhibited
DYNA-IND entry of IAV (Fig. 9A–B). Remarkably, 17-AA-
geldanamycin, a specific inhibitor of the chaperone protein HSP90
[53], also caused specific inhibition of DYNA-IND entry (Fig. 9A–
B). HSP90 affects the folding and activity of many proteins but the
recent demonstration of direct activation of the catalytic activity of
src by HSP90 [54] provides another indication of the involvement
of src in DYNA-IND endocytosis of IAV.
In conclusion, like for other viruses utilizing a macropinocytic
entry pathway, PAK1 seems to play a crucial role in DYNA-IND
entry by IAV. However, this pathway is independent of Rac1 or
cdc42 but may require src, either upstream and/or downstream of
PAK1.
Discussion
The data presented in this study demonstrate for the first time
that IAV can enter cells via DYNA-IND macropinocytosis in
addition to the previously described DYNA-DEP classical CME
pathway [1,2]. Several lines of evidence indicate that the DYNA-
IND entry route of IAV that we identified corresponds with
macropinocytosis. First of all, the entry pathway is dependent on
the presence of serum, a well-known inducer of macropinocytosis.
Second, IAV colocalized in vesicles with soluble FITC-dextran, a
marker for macropinocytosis. Third, DYNA-IND IAV entry was
sensitive to the amiloride-derivative EIPA, the hallmark inhibitor
of macropinocytosis [14,55–58]. Fourth, this IAV entry pathway is
sensitive to inhibitors or dominant-negative mutants affecting
actomyosin dynamics. Fifth, the specific inhibition of DYNA-IND
IAV entry by a number of inhibitors of growth factor receptor
tyrosine kinases as well as downstream effectors thereof also points
at the involvement of macropinocytosis. Finally, macropinocytosis
is independent of dynamin [12,14,19].
Despite this extensive list of arguments, viral entry by
macropinocytosis needs to be considered with caution. The
characteristics of the DYNA-IND route of cell entry by IAV are
similar, but not identical to the macropinocytic entry routes taken
by other viruses, like two different strains of vaccinia virus and by
coxsackie virus B [34,35]. As is shown in Table 1 and discussed in
Figure 9. The DYNA-IND IAV entry pathway is sensitive to inhibitors of PAK1, src and HSP90. Inhibitors of PAK1 (40 mM IPA-3), src (10 mM
PP2) or HSP90 (5 mM aa-geldanamycin (GELD)) were examined for their effect on DYNA-DEP (A) or DYNA-IND (B) entry using the Gluc-entry assay
(HeLa cells; strain WSN; MOI 0.5; incubation with inhibitors from 1 hr prior to infection to 2 hrs p.i.). Inhibitors of Rac1 (80 mM and 160 mM NSC23766
(NSC)), Cdc42 (12.5 mM and 3.125 mM Pirl1) and N-WASP (10 mM and 5 mM wiskostatin (WIS)) were examined for their effect on DYNA-DEP (C) or
DYNA-IND (D) entry using the Gluc-entry assay (HeLa cells; strain WSN; MOI 0.5; pre-incubation with inhibitors 1 hr prior to infection) and on infection
by vaccinia virus (E). When Wiskostatin, NSC23766 or Pirl1 were added at t=2 in order to check for their effect on replication we observed a dose-
dependent inhibition by Pirl1 (60% inhibition at 12 uM) and no effect by wiskostatin or NSC23766 (result not shown).
doi:10.1371/journal.ppat.1001329.g009
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these viruses have a few unique characteristics. This may very well
reflect the growing notion that macropinocytosis represents a
number of differentially induced and regulated processes, rather
than being a single endocytic pathway [13,14]. Macropinocytosis
has collectively been described as an inducible form of endocytosis
by which fluid-phase cargo travels via non-coated, relatively large
and heterogeneous organelles that have emanated from extensive
protrusions (e.g lamellar ruffles, circular ruffles or retracting blebs)
of the plasma membrane [13]. In the case of DYNA-IND IAV
entry more extensive studies using electron microscopy will be
required to study the morphology of membrane protrusions with
which IAV may associate. In addition, live cell imaging
microscopy will be required to characterize the exact itinerary
that is taken by IAV virions traveling via a macropinocytic process.
This is especially important as different routes of IAV entry are
likely to converge at some point in the endocytic pathway.
Although unlikely, co-localization of IAV particles with fluid-phase
dextran as shown in Fig. 8B may thus represent a situation
occurring after convergence of several different routes. The use of
microscopy to study macropinocytosis is however complicated by
the lack of specific membrane-associated markers for any early
step of this endocytic process.
A model (Fig. 10) based on our results explains the key steps
involved in the macropinocytic entry pathway of IAV, which are
described in more detail below.
By manipulating the inoculation conditions we were able to
experimentally dissect IAV entry into a DYNA-DEP and DYNA-
IND route. The DYNA-IND route required the presence of 10%
FCS in the entry assay medium. Previously, a strict dependency on
a DYNA-DEP entry route for IAV was concluded from
experiments with a cell line expressing an inducible dominant-
negative mutant of dynamin 2 [59]. In that study, as well as in
other entry studies of IAV, entry was performed in DMEM
containing 2% serum or BSA. Also in our hands 2.5% serum
(Fig. 2A) or 0.2% BSA (result not shown) was not sufficient to allow
DYNA-IND entry. We are currently investigating which serum
component is responsible for the observed effects on IAV entry.
Dialysis of FCS (MW cut off .10 kDa) did not affect its capacity
to induce DYNA-IND endocytosis (result not shown), indicating
that low molecular weight solutes are not responsible for the
observed effect.
Our evidence for a DYNA-DEP and a serum inducible DYNA-
IND entry route is based on the use of pharmacological (dynasore,
a highly specific inhibitor of dynamin) as well as genetic (siRNA
directed against dynamin 2) tools, ruling out the possibility that the
inhibitory effect of dynasore was due for instance to absorption of
the inhibitor by serum components. Whereas dynasore resulted in
near 100% inhibition of DYNA-DEP entry, only 65% inhibition
was observed upon siRNA induced silencing of dynamin 2
indicating that the residual levels of dynamin 2 that remain after
48 hrs of silencing still support a low level of DYNA-DEP entry
(Fig. 4H). Reversible inhibitors like dynasore [60] offer a major
advantage for characterization of IAV entry pathways. They can
be applied for a limited period thus preventing the secondary
adaptive effects of cells that may occur in response to long-term
down regulation of a gene product by genetic methods like siRNA
interference. Both entry routes were consistently identified by a
viral entry assay quantified by virus induced expression of a
luciferase reporter as well as by a VLP entry assay allowing direct
analysis of the membrane fusion mediated entry step. The
consistent performance of an HA with a strict preference for
Table 1. DYNA-IND entry of IAV is similar, but not identical, to macropinocytic entry of other viruses.
IAV IAV VV VV CVB
Dynamin dependent Dynaminindependent WR IHD-J
Fluid uptake
Induction NO YES YES YES
Co-localization NO YES YES YES
Cytoskeleton
Actin NO YES YES YES
Myosins NO YES YES YES
GTPases
Rac1 NO NO YES YES/NO NO
Cdc42 NO NO YES/NO YES
Rab5 YES YES YES YES YES
Kinases
PAK1 NO YES YES YES
PI(3)kinase YES YES YES NO
Receptor Tyrosine kinases NO YES YES YES
Protein kinase C YES/NO YES YES YES YES
SFK (src family kinases) NO YES YES
Others
Na+/H+ exchange NO YES YES YES YES
Acidification YES YES YES NO NO
Dynamin 2 YES NO NO NO NO
Data for IAV entry are from this article. Data for vaccinia virus are from [34] and for coxsackie B virus from [35]. Table adapted from [14].
doi:10.1371/journal.ppat.1001329.t001
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unpublished data) and an HA also binding to a2-6 linked sialic
acids (from 1918 IAV [61]) in the VLP entry assay indicates that
both pathways can be utilized by HAs of different specificity and
may therefore be relevant to avian as well as human IAV
infections. Consistently, serum-inducible DYNA-IND entry was
observed both in avian DF1 cells and in a human lung epithelial
carcinoma cell line A549 (Fig. 3).
The DYNA-DEP and DYNA-IND IAV entry pathways were
found by our quantitative assays to be fully redundant. In the
presence of serum, the combination of dynasore (inhibiting
DYNA-DEP entry) and EIPA (inhibiting DYNA-IND entry)
completely abolished entry whereas either drug alone had no
effect. EIPA, an inhibitor of plasma membrane Na+/H+
exchangers, has been shown to invariably inhibit macropinocytosis
[14,55–58]. As other routes of endocytosis are generally not
affected, EIPA is considered as a hallmark inhibitor of macro-
pinocytosis [14], although results obtained with EIPA should be
considered with care as long as a mechanistic explanation for its
effect on macropinocytosis is not yet fully clear [62]. Occasionally,
a moderate two- to three-fold inhibition by dynasore alone was
observed (result not shown) indicating that the capacity of the
serum-inducible entry pathway is somewhat variable, possibly
depending on slight variations in serum quality and factors like cell
distribution in the wells that have been reported to influence viral
infection [63]. A redundancy in the utilization of CME as well as a
clathrin-independent route for entry of IAV has been visualized
previously by quantitative live cell imaging [4]. Both routes were
operative simultaneously in the same sample and the specific
down-regulation of CME did not affect the total number of entry
events.
In response to specific extra-cellular signals (e.g. serum
induction), changes in the actomyosin network occur that give
rise to membrane protrusions required for macropinosome
formation [13]. Compounds inhibiting actin polymerization
(cytochalasin B and D), depolymerization (jasplakinolide) or
sequestering soluble actin (latrunculin A) all specifically inhibited
DYNA-IND IAV entry. In addition, the requirement for myosinII
activity was established by a specific inhibitor (Blebbistatin) of
myosin II ATPase activity and by the expression of a dominant
negative mutant of myosinIIA heavy chain. Also, the regulation of
myosinII activity by phosphorylation of myosin light chain
through the action of MLCK is suggested by the inhibitory effect
of MLCK inhibitors ML-7 and ML-9 as well as by the similar
effect of an expressed MLCK dominant negative mutant.
Recently, a function for the actin cytoskeleton in IAV entry was
reported to be required for the entry into polarized epithelial cells
but not for entry into non-polarized cells [64]. When using the
low-serum conditions used in that paper (2% FCS), we only
observed DYNA-DEP entry that was not affected by actin
dynamics inhibitors. Perhaps, the polarized cells permit DYNA-
IND entry at lower serum concentrations.
The changes in actin network dynamics that can lead to the
formation of macropinosomes can be triggered by a number of
signaling cascades. Actin dynamics are induced by the activation
of growth factor receptor tyrosine kinases by their respective
Figure 10. A model for IAV entry by macropinocytosis. The model summarizes the inhibitory (red boxes) or stimulatory (blue boxes) effects of
compounds on dynamin-independent IAV entry. The effect of over-expression of dominant-negative mutants is indicated by red-lined boxes. The
pathway requires the presence of serum factors in the entry medium and results in the enhanced uptake of dextran and its co-localization with IAV in
large vesicles (green boxes). We hypothesize that the interaction of serum factors and/or IAV with receptor tyrosine kinases (RTKs) is the primary
signal for the induction of macropinocytosis. A number of RTKs have been shown to be involved in this process in different cell lines. Remarkably, a
recently published genome-wide siRNA screen of IAV infection identified the FGF receptor as a host factor required for influenza virus replication [22].
Activation of Rho family GTPases CDC42 and/or Rac1 has been shown to be essential for signal transduction leading to macropinocytosis in many
cases [13,14] but inhibitors are without effect or are stimulatory in the case of IAV entry. Downstream effectors of Rho family GTPases include scaffold
proteins like N-WASP and WAVE and protein kinases like PAK1. Macropinocytic entry of IAV however seems to require a Rho family GTPase-
independent PAK1 activation mechanism. In addition, src family kinases, which can be directly activated by RTKs, play a role. PAK1 and src have
previously been linked to the activation of macropinocytosis via their effect on changes in actomyosin dynamics, a process which is crucial to any
form of macropinosome formation [13,14]. Apart from N-WASP- or WAVE-containing macromolecular assemblies other actin binding proteins can
induce such changes (e.g. cortactin, which can be activated by src [81]) and thereby induce the formation of one of the different plasma membrane
protrusions that can result in the formation of macropinosomes. In addition to an effect on the formation of plasma membrane protrusions and
subsequent macropinosome formation, inhibitors can also affect downstream trafficking and maturation of macropinosomes which might be actin-
dependent, but this is not depicted in the scheme.
doi:10.1371/journal.ppat.1001329.g010
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14,17,36,37] The signal transduction cascades that link activation
of growth factor receptor tyrosine kinases to actin remodeling and
macropinocytosis are only beginning to be revealed. The specific
inhibition of DYNA-IND entry of IAV by IPA3, an inhibitor of
PAK1, provides proof for the involvement of these cascades.
PAK1 is a key serine/threonine kinase regulating actin network
dynamics but its crucial function in several pathways of
endocytosis as well as numerous other cellular processes does not
make it a very specific marker [65]. Even so, macropinocytosis has
consistently been demonstrated to require PAK1 activation, both
in the induction of the process and/or in further downstream
trafficking events of macropinosomes [13,14].
Growth factor dependent activation of PAK1 has most often
been demonstrated to depend on upstream activation of small
GTPases Rac1 or cdc42 [34,40,41]. Different strains of vaccinia
virus were recently shown to induce their uptake by macro-
pinocytosis via activation of either Rac1 or cdc42 [34]. Activation
of Rac1 has been linked to the induction of macropinocytosis via
actin network-mediated formation of lamellipodia and/or circular
ruffles whereas cdc42 has most often been implied in the formation
of filopodia [44]. An inhibitory effect of the Rac1 inhibitor
NSC23766 or the cdc42 inhibitor pirl1 on IAV entry, however,
could not be demonstrated. Remarkably, cdc42 inhibitor pirl1
enhanced IAV entry and a similar effect was observed by
wiskostatin, an inhibitor of N-WASP which functions directly
downstream of cdc42 as a scaffolding complex required for the
activation of actin polymerization leading to filopodia formation.
Similarly, the macropinocytosis-like entry pathway taken by
Coxsackie B virus was also shown to require PAK1 activity that
was independent of Rac1 activation [35]. Direct examination of
the magnitude and timing of the activation of PAK1 will be
required to obtain more insight in the involvement of this complex
pathway. The induction of macropinocytosis by a PAK1-
dependent mechanism has been associated with ruffling at the
cell membrane [12,14,15,37]. The identification of sub-membra-
nous regions with increased actin staining by phalloidin has been
interpreted as evidence for ruffling. This was not unambiguously
identified by confocal microscopy in the experiments presented in
Fig. 8 and Fig. S2 and needs to be investigated in depth by life cell
imaging techniques.
In agreement with our observation that the DYNA-IND entry
of IAV was inhibited by PP2, an inhibitor of src family kinases, the
non-receptor tyrosine kinase c-src has been shown to function as a
key signaling intermediate in the induction of macropinocytosis via
a mechanism independent of Rac1 or cdc42 [49–51]. Downstream
effects of c-src on actin networks proceed, amongst others, via
phosphorylation of cortactin by c-src resulting in accelerated
macropinosome formation [50]. C-src has been shown to associate
with macropinosomes [49,51], both during their formation and
their trafficking, while c-src kinase activity is required for
macropinocytosis following EGF stimulation of HeLa cells [49].
Interaction of HSP90 with c-src was recently shown to induce c-src
kinase activity [54]. Also HSP90 has been demonstrated to
associate with macropinosomes, while its specific inhibitor
geldanamycin reduced the membrane ruffling that preceded
macropinocytosis [66]. Thus, the inhibition of IAV entry via
macropinocytosis by AA-geldanamcyin may very well involve the
effects of HSP90 on c-src.
As detailed above, the DYNA-IND entry pathway of IAV
shares many characteristics with the endocytic pathway macro-
pinocytosis. This is corroborated by the observation that IAV
particles and dextran colocalize in large vesicles in the presence of
FCS. Several viruses have recently been reported to enter cells via
macropinocytosis [12,14]. Apart from common factors like the
requirement for PAK1 activation, actin dynamics and indepen-
dence of dynamin, virus specific details have been described
[34,35] (Table 1). In part these might be contributed to differences
in experimental conditions (e.g. cell types tested) but diversity in
the molecular mechanisms by which macropinocytosis can be
induced and executed is likely to exist and to be exploited by
viruses. Whereas vaccinia virus is able to trigger its own
macropinocytic uptake [34,43], we have described a macropino-
cytosis pathway that is operational under conditions that are
activated by components in serum. Still, this does not exclude
signaling induced by virus-host cell interactions, which are for
instance suggested by the significant increase of FITC-dextran
uptake in the presence of IAV. The possible requirement for co-
stimulatory signals from serum components and virus imposes an
additional layer of complexity on the analysis of IAV entry via
DYNA-IND pathways.
Influenza viruses cause respiratory infections by targeting the
epithelial cells lining the respiratory tract. These surfaces are
covered by a mucous layer composed of a variety of small solutes
and glycoproteins derived among others from goblet cells [67].
This semi-fluid layer in turn conditions the underlying cells and
determines their physiological state, including the activities of their
uptake and secretion pathways. It will be important to determine
to what extent the DYNA-DEP and DYNA-IND IAV entry
pathways are operational under the conditions prevailing along
the respiratory tract. Current knowledge on the protein compo-
sition of the fluids covering the respiratory epithelium is rapidly
expanding by the application of proteomic methods to determine
the protein composition of bronchial alveolar lavage fluids (BALF).
These studies have extended the previous notion that BALF is
highly similar in composition to serum. For example, just as for the
serum proteome more than 85% of the total protein mass of the
BALF proteome is accounted for by albumin, immunoglobulins,
transferring, a1-antitrypsin and haptoglobin. In addition, many
other proteins have been identified both in serum and in BALF
including growth factors that can bind to growth factor receptor
tyrosine kinases [68–70]. Thus, BALF is likely to harbor, just as
serum, the protein factors that can activate signaling pathways that
are crucial for the induction of DYNA-IND entry of IAV. In
agreement herewith, macropinocytosis has been described as a
functional entry pathway of Haemophilus influenzae into primary
human bronchial epithelial cells [71] although the factors involved
in signaling the process have not been identified yet.
In addition to infecting the respiratory tract, IAV has been
shown to be able to cause systemic infections involving multiple
organs. This has mainly been studied in avian infections [72,73] or
by infection of mice with human-derived H1N1 or H3N2 IAVs
[74] but is poorly documented for human infections and may have
been underestimated thus far. Obviously, during potential
systemic spreading of IAV, the serum-rich conditions that we
have demonstrated here to enable the use of alternative entry
pathways will be encountered and may contribute to such
spreading.
Material and Methods
Cells and viruses
MDCK, A549, DF-1 and HeLa cells were maintained in
complete Dulbecco’s Modified Eagle’s Medium (DMEM) (Lonza,
Biowittaker) containing 10% (v/v) fetal calf serum (FCS; Bodinco
B.V.), 100 U/ml Penicillin, and 100 mg/ml Streptomycin. Chi-
nese Hamster-E36 cells were maintained at 37uCi na-Minimal
Essential Medium (Gibco) supplemented with 10% (v/v) FCS,
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passaged twice weekly. Influenza A/WSN/33 (H1N1) (IAV-WSN)
was grown in MDCK cells. Briefly, ,70% confluent MDCK cells
were infected with IAV-WSN at a MOI of 0.02. Supernatant was
harvested after 48 hr of incubation at 37uC and cell debris was
removed by centrifigutation (10 min at 2000 rpm). Virus was
stored at 280uC and virus titers were determined by measuring
the TCID50 on HeLa cells. The IAV-WSN luciferase pseudovirus
(WSN-Ren) system has previously been described [27]. Briefly,
WSN-Ren pseudovirus harbors a HA segment in which the HA
coding region is replaced by Renilla luciferase. The pseudovirus is
produced in a MDCK cell line that stably expresses the HA of
IAV-WSN. WR-LUC, a firefly luciferase encoding vaccinia virus
(strain WR) was previously described [75]. VSV-FL, a firefly
luciferase encoding VSV virus was also previously described [76].
Chemicals
Stocks of bafilomycin A1 (BafA1), dynasore, cytochalasin D,
cytochalasin B, Blebbistatin, 17-AA-geldanamycin, ML-7, ML-9,
PP-2, 5-(N-ethyl-N-isopropyl)amiloride (EIPA), IPA-3 (all obtained
from Sigma-Aldrich), Latrunculin A (Enzo), jasplakinolide,
wiskostatin, NSC23766 (all obtained from Calbiochem) and pirl1
(Chembridge) were prepared in dimethylsulfoxide (DMSO). All
stocks were stored at 220uC. A kinase inhibitor library composed
of 80 kinase inhibitors was obtained from Biomol (2832A[V2.2]).
Neuraminidase treatment
HeLa cells (10,000 cells/well in 96-well plates) were treated with
2 mUnits of Vibrio cholerae neuraminidase (Roche) in 50 ml
phosphate-buffered saline (PBS) for 2 hr. After washing with
PBS cells were infected with IAV as described.
Virus-like particle assay
Virus-like particles (VLPs) were produced as described [26].
Briefly, 293T cells were transfected using Lipofectamine 2000
(Invitrogen) with pCAGGS-BlaM1 (encoding a beta-lactamase
reporter protein fused to the influenza matrix protein-1),
pCAGGS-HA (encoding HA derived from either A/NewYork/
1/1918 or IAV-WSN) and pCAGGS-NA (encoding IAV
neuraminidase [NA] derived from either A/BrevigMission/1/18
or IAV-WSN) and maintained in OptiMEM. Supernatants were
harvested 72 h after transfection and centrifuged to remove debris.
VLPs were used for inoculation of cells without further
concentration. VLPs were incubated for 30 min at 37uC with
trypsin/TPCK for activation of HA. MDCK or HeLa cells grown
to near confluency in 24-well plates were inoculated with 250 ul of
VLPs after pre-treatment of the cells with inhibitors as indicated.
Infection was synchronized by centrifugation at 1500 rpm for
90 min at 4uC and was performed by further incubation at 37uC
for 2 h in the absence or presence of 10% FCS and inhibitors as
indicated. Detection of beta-lactamase activity was performed as
described [25] by loading cells with CCF2-AM substrate
(InVitrogen) and subsequent analysis by flow cytometry on a
LSRII flow cytometer (Becton Dickinson). Typically 10,000 events
were collected and analyzed using FlowJo 8.5.2 software.
Luciferase assays
The reporter construct pHH-Gluc was derived from plasmid
pHH-Fluc [22] by replacing the firefly luciferase coding region
with the Gaussia luciferase coding region of pGluc-basic (New
England Biolabs). Unique SpeI and XbaI restriction sites were
introduced into pHH-Fluc using the Quikchange XL Site-directed
mutagenesis kit (Stratagene) and oligonucleotides Spe4262 (5-
9GCCTTTCTTTATGTTTTTGGCACTAGTCATTTTACCG-
ATGTCACTCAG), Spe4263 (59-CTGAGTGACATCGGTAA-
AATGACTAGTGCCAAAAACATAAAGAAAGGC), Xba4260
(59-GTATTTTTCTTTACAATCTAGACTTTCCGCCCTTC-
TTGG) and Xba4261 (CCAAGAAGGGCGGAAAGTCTAG-
ATTGTAAAGAAAAATAC). A SpeI site was introduced by site-
directed mutagenesis in pGluc-basic directly following the start
codon of the Gaussia luciferase coding sequence. The unique SpeI
– XbaI fragment of pGluc-basic was subsequently cloned into the
SpeI-XbaI site of pHH-Fluc resulting in plasmid pHH-Gluc.
Cells were seeded in 96-well plates at a density of 10,000 cells/
well and transfected the next day with 10 ng pHH-Gluc using
Lipofectamine 2000 (InVitrogen) according to the manufacturer’s
protocol. After 24 hrs the transfected cells were treated with
inhibitors and infected as indicated. At 16 hr p.i. samples from the
supernatant were assayed for luciferase activity using the Renilla
Luciferase Assay system (Promega) according to the manufactur-
er’s instructions, and the relative light units (RLU) were
determined with a Berthold Centro LB 960 plate luminometer.
WR-LUC and VSV-FL were used to inoculate HeLa cells (10,000
cells/well) at an MOI of 2, in complete Dulbecco’s Modified
Eagle’s Medium (DMEM) (Lonza, Biowittaker). After 7 hr the
luciferase activity was detected using the SteadyGlo assay kit
(Promega). The addition of 10% (v/v) FCS did not change
infection levels for both viruses.
Confocal immunofluorescence microscopy
Cells were fixed with 3.7% paraformaldehyde (PFA) in PBS and
subsequently permeabilized with 0.1% Triton-X-100 in PBS. After
blocking with normal goat serum IAV-infected cells were
incubated for 1 h with a monoclonal antibody directed against
the nucleoprotein (NP) (HB-65; kindly provided by Dr. Ben
Peeters). After washing, the cells were incubated with a 1:400
dilution of Alexa Fluor 488- or 568-labeled goat anti-mouse IgG
(Molecular Probes) secondary antibody for 1 h. Nuclei were
subsequently stained with TOPRO-3 and after three washing
steps, the coverslips were mounted in FluorSave (Calbiochem).
Actin was stained using phalloidin labeled with Alexa Fluor 633.
The immunofluorescence staining was analyzed using a confocal
laser-scanning microscope (Leica TCS SP2). FITC, GFP or Alexa
Fluor 488 were excited at 488 nm, Alexa Fluor 568 at 568 nm,
and TOPRO-3 at 633 nm.
FITC-dextran uptake
HeLa cells were grown in 24-well plates on glass coverslips
(50,000 cells/well). Prior to FITC-dextran uptake cells were
serum-starved for 2 hr in PBS. FITC-dextran (MW70,000, Sigma-
Aldrich) was incubated with HeLa cells (final concentration of
0.5 mg/ml) in 500 ml PBS or in PBS containing 10% FCS in the
absence or presence of IAV (strain WSN; MOI 10; concentrated
and purified by centrifugation through a 15 to 30% sucrose
gradient with a 50% sucrose cushion at the bottom) at 37uC. After
15 min cells were washed 4 times with PBS at 4uC, fixed with
3.7% PFA in PBS and subsequently permeabilized with 0.1%
Triton-X-100 in PBS. Slides were stained for examination by
confocal microscopy as described above. For quantification of
FITC-dextran uptake 1.5610
5 HeLa cells were infected with IAV-
WSN (MOI 10) in suspension in a volume of 1 ml in the presence
of FITC-Dextran (1 mg/ml). Infections were performed for
15 min in PBS (containing 2% BSA to reduce unspecific binding
of FITC-Dextran) or in PBS containing 10% FCS at 37uCo ra t
4uC (control for binding of FITC-Dextran to cells in the absence of
endocytosis). Mock-infected samples were analysed in parallel.
Infection was terminated by addition of 3 ml ice-cold PBS
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PFA. 20,000 cells were analyzed by FACS and results were
represented as the mean fluorescence which was plotted relative to
the uptake in the mock-infection in PBS (after subtraction of
background fluorescence obtained at 4uC).
The effect of dynasore and EIPA on dextran and
transferrin uptake
HeLa cells (grown on glass cover slips) were incubated at 4uC
for 1 hr with 50 mg/ml Alexa633-labeled Transferin (InVitrogen)
in PBS. After 1 hr the medium was replaced by PBS or PBS
supplemented with 10% FCS containing IAV (strain WSN; MOI
10) and 0.5 mg/ml FITC-Dextran (Sigma; 70 kDa) and cells were
transferred to 37uC for 15 min. After 15 min cells were fixed and
stained as described above and examined by confocal microscopy.
Immunocytochemistry
Cells were fixed with 3.7% PFA in PBS and subsequently
permeabilized with 0.1% Triton-X-100 in PBS. Peroxidase was
visualized using an AEC substrate kit from Vector Laboratories.
IAV-positive cells were detected using bright-field light microscopy.
Dynamin 2 knockdown
Two siRNA duplexes targeting different sites within the coding
sequences of dynamin 2 were obtained from Ambion Inc (15581
(Dynamin 2 siRNA 1) and 146559 (dynamin 2 siRNA2)). A
scrambled siRNA (Ambion Inc.) was taken along as a control for
non-specific effects of the transfection procedure and was used for
normalization. One day after seeding in 96-well plates (6,000
cells/well), the HeLa cells were transfected with a final
concentration of 10 nM siRNA using oligofectamine (Invitrogen).
48 h after transfection, the cells were inoculated with the WSN-
Ren pseudovirus (MOI 0.5) in PBS or in PBS containing 10%
FCS. After 2 h of infection the entry medium was replaced by
complete growth medium containing 10 nM BafA1 to prevent
further entry. At 16 h post infection intracellular Renilla luciferase
expression was determined as described above. Each siRNA
experiment was performed in triplicate. Cell viability was not
affected as determined by performing a Wst-1 cell-viability assay
(Roche). Functional knockdown of dynamin 2 mRNA levels was
performed by quantitative RT-PCR. using a TaqMan Gene
Expression Assay for DNM2 (Hs00191900_m1, Ambion) and
using 18S RNA (Hs03928985_g1, Ambion) as a control for
normalization. The comparative Ct-method was used for
quantification of the results [77]. Reduction of dynamin 2
protein levels was determined by western blotting using
polyclonal goat-anti-dynamin 2 C18 (Santa-Cruz SC-6400). A
monoclonal against alpha-tubulin (DM1A, Sigma T9026) was
used to detect tubulin for normalization. Results were quantified
by Densitometric scanning of the dynamin 2 and tubulin signals
displayed in Fig. 4H.
Dominant negative constructs
HeLa cells were grown in 24-well plates on glass coverslips
(50,000 cells/well) for 24 hrs. Cells were then transfected (1 mgo f
DNA with lipofectamine 2000 as described above) with plasmids
encoding wild-type or dominant-negative (DN) human MLCK
fused to GFP [78], wild-type or DN Rab5 fused to GFP [79], or
MyoII-tail or MyoII-head domain fused to GFP [80]. 24 hr after
transfection cells were inoculated with IAV-WSN (MOI 1) in PBS
or in PBS containing 10% FCS and 80 mM dynasore. 4 hr after
infection cells were fixed and stained for examination by confocal
microscopy as described above.
Statistical analysis
An unpaired Student’s t-test was used for detemination of
statistically significant differences. The use of the term significant
in text refers to a comparison of values for which p,0.05.
Supporting Information
Figure S1 The effect of 80 mM EIPA, 80 mM dynasore (DY) or
80 mM of both inhibitors (DY+EI) on DYNA-DEP (A–D) or
DYNA-IND (E–F) entry was examined in the Gluc-entry assay
(HeLa cells (A,E); A549 cells (B,F); 293T cells (C,G); CHO K1
cells (D,H); strain WSN; MOI 0.5; incubation with EIPA or DY
from 21 hr to 2 hr p.i.). Data were plotted relative to the control
(0.2% DMSO).
Found at: doi:10.1371/journal.ppat.1001329.s001 (3.57 MB TIF)
Figure S2 The effect of EIPA and dynasore on transferrin or
dextran uptake in HeLa Cells. (A) Uptake of Alexa633-labeled
transferrin (red) in PBS (upper row) or in 10% FCS (second row) in
the presence of IAV (MOI 10). (B) Uptake of FITC-labeled
dextran (green) in PBS supplemented with 10% FCS in the
presence of IAV (MOI 10). Uptake was performed in absence
(CONTROL) of inhibitor or in the presence of 80 mM dynasore
(DY) or 80 mM EIPA. Contours of the cells are indicated by a gray
line. Eight z-stacks of each slide were inspected to assure that
transferrin and dextran were inside the cells.
Found at: doi:10.1371/journal.ppat.1001329.s002 (7.60 MB
TIF)
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